Jun 08, 2021 / 08:40PM GMT
Graig Suvannavejh - Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst
Yes. Okay. Good afternoon, everyone. Welcome to the 4:40 p.m. session on day 1 of the 42nd Annual Goldman Sachs Global Health Care Conference. My name is Graig Suvannavejh. I cover both U.S. and European biopharma names here at the firm. It's my pleasure to be hosting Kodiak Sciences today in a fireside chat. And with that, let me welcome Victor Perlroth, who's CEO of the company; and John Borgeson, who is CFO of the company, who is just slightly to the side of your screen.
Questions and Answers:
Graig Suvannavejh - Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research AnalystBut with that said, Victor, it's good to see you. Thank you again for your participation. And maybe if I can just start everyone at a very high level for those who are perhaps newer to the Kodiak Sciences story or perhaps revisiting it after some time, can you please just tell us a little bit more about the company and
Trustpilot
